Editas Medicine Inc (EDIT)
2.12
+0.24%
Editas Medicine Inc (EDIT) is currently trading at $2.12. This represents a gain of 0.24% from the previous session. With a market capitalization of $0.21B, EDIT is a key component of the Health Care sector. Investors looking to trade EDIT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade EDIT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Editas Medicine Inc (EDIT) shows a bullish trend. Analysts are watching the 2.23 level closely.
Fundamentals
Mkt Cap0.21B
P/E Ratio0.0000
Volume1,097,633
60-Day Technical Chart
Advanced Charting
Need more indicators for EDIT? Use the world's #1 platform.
Open EDIT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $2
| Metric |
EDIT +0.24% |
PLUG +1.05% |
RIME -9.17% |
CLOV +3.73% |
|---|---|---|---|---|
| Price | $2.12 | $1.93 | $1.98 | $2.09 |
| Mkt Cap | $0.21B | $2.69B | $0.01B | $1.08B |
| - | View → | View → | View → |
Latest Headlines
Gene editor Editas brings its story to Boston and Miami investors
Stock Titan • Feb 23, 2026
Why Editas Medicine Stock Was Skyrocketing This Week
The Motley Fool • Aug 15, 2025
$EDIT stock is up 10% today. Here's what we see in our data.
Quiver Quantitative • Oct 15, 2025
Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance • May 13, 2025
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
GlobeNewswire • Nov 10, 2025
● Gemini Agentic AI Analyst Insight for EDIT
Market Education
- Finding Stocks in the Squeeze Zone: Using Finviz Jun 2, 2024
- Stocks with Cash and Low Debt Dec 10, 2023
- 🔥 Top 7 AI Penny Stocks That Could Explode in 2025 Nov 16, 2025
External Research